ABCG2 is overexpressed on red blood cells in Ph-negative myeloproliferative neoplasms and potentiates ruxolitinib-induced apoptosis
Date
2021-04-01
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Buks, R, Brusson, M, Cochet, S, Galochkina, T, Cassinat, B, Nemazanyy, I, Peyrard, T, Kiladjian, J J, de Brevern, A G, Azouzi, S & Nemer, W E 2021, 'ABCG2 is overexpressed on red blood cells in Ph-negative myeloproliferative neoplasms and potentiates ruxolitinib-induced apoptosis', International Journal of Molecular Sciences, vol. 22, no. 7, 3530. https://doi.org/10.3390/ijms22073530